Doximity Announces Fiscal 2025 Third Quarter Financial Results

Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024.

“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” said Jeff Tangney, co-founder and CEO of Doximity. “Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”

Fiscal 2025 Third Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended December 31, 2023.

• Revenue: Revenue of $168.6 million, versus $135.3 million, an increase of 25% year-over-year.

• Net income and non-GAAP net income: Net income of $75.2 million, versus $48.0 million, representing a margin of 44.6%, versus 35.4%. Non-GAAP net income of $91.4 million, versus $58.5 million, representing a margin of 54.2%, versus 43.2%.

• Adjusted EBITDA: Adjusted EBITDA of $102.0 million, versus $73.3 million, an increase of 39% year-over-year, representing adjusted EBITDA margins of 60.5%, versus 54.2%.

• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.37, versus $0.24, while non-GAAP diluted net income per share was $0.45, versus $0.29.

• Operating cash flow and free cash flow: Operating cash flow of $65.2 million, versus $50.1 million, an increase of 30% year-over-year, and free cash flow of $63.4 million, versus $48.7 million, an increase of 30% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2025 as follows:

• Revenue between $132.5 million and $133.5 million.

• Adjusted EBITDA between $62.5 million and $63.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2025 as follows:

• Revenue between $564.6 million and $565.6 million.

• Adjusted EBITDA between $306.6 million and $307.6 million.

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

December 31, 2024

 

March 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

165,270

 

$

96,785

 

Marketable securities

 

679,670

 

 

666,115

 

Accounts receivable, net

 

137,504

 

 

101,332

 

Prepaid expenses and other current assets

 

30,259

 

 

48,709

 

Total current assets

 

1,012,703

 

 

912,941

 

Property and equipment, net

 

13,477

 

 

12,318

 

Deferred income tax assets

 

43,079

 

 

45,068

 

Operating lease right-of-use assets

 

9,332

 

 

12,332

 

Intangible assets, net

 

24,134

 

 

27,317

 

Goodwill

 

67,940

 

 

67,940

 

Other assets

 

1,492

 

 

1,458

 

Total assets

$

1,172,157

 

$

1,079,374

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

1,636

 

$

2,253

 

Accrued expenses and other current liabilities

 

42,793

 

 

43,703

 

Deferred revenue, current

 

69,197

 

 

99,145

 

Operating lease liabilities, current

 

2,255

 

 

2,149

 

Total current liabilities

 

115,881

 

 

147,250

 

Deferred revenue, non-current

 

73

 

 

211

 

Operating lease liabilities, non-current

 

10,692

 

 

12,397

 

Contingent earn-out consideration liability, non-current

 

5,498

 

 

10,895

 

Other liabilities, non-current

 

8,893

 

 

7,224

 

Total liabilities

 

141,037

 

 

177,977

 

Stockholders' Equity

 

 

 

Preferred stock

 

—

 

 

—

 

Common stock

 

188

 

 

187

 

Additional paid-in capital

 

878,701

 

 

823,885

 

Accumulated other comprehensive income (loss)

 

1,015

 

 

(2,664

)

Retained earnings

 

151,216

 

 

79,989

 

Total stockholders’ equity

 

1,031,120

 

 

901,397

 

Total liabilities and stockholders’ equity

$

1,172,157

 

$

1,079,374

 

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

Revenue

$

168,603

 

$

135,284

 

$

432,111

 

$

357,365

Cost of revenue(1)

 

14,181

 

 

12,190

 

 

41,407

 

 

38,102

Gross profit

 

154,422

 

 

123,094

 

 

390,704

 

 

319,263

Operating expenses(1):

 

 

 

 

 

 

 

Research and development

 

22,421

 

 

19,946

 

 

68,235

 

 

61,835

Sales and marketing

 

38,491

 

 

34,956

 

 

108,102

 

 

99,612

General and administrative

 

13,585

 

 

9,641

 

 

32,943

 

 

27,854

Restructuring and impairment charges

 

—

 

 

—

 

 

2,304

 

 

7,936

Total operating expenses

 

74,497

 

 

64,543

 

 

211,584

 

 

197,237

Income from operations

 

79,925

 

 

58,551

 

 

179,120

 

 

122,026

Other income, net

 

9,915

 

 

4,481

 

 

26,060

 

 

15,223

Income before income taxes

 

89,840

 

 

63,032

 

 

205,180

 

 

137,249

Provision for income taxes

 

14,644

 

 

15,076

 

 

44,453

 

 

30,285

Net income

$

75,196

 

$

47,956

 

$

160,727

 

$

106,964

Net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

$

0.40

 

$

0.26

 

$

0.86

 

$

0.56

Diluted

$

0.37

 

$

0.24

 

$

0.80

 

$

0.52

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

187,161

 

 

186,309

 

 

186,344

 

 

191,302

Diluted

 

202,233

 

 

200,463

 

 

200,625

 

 

207,265

(1) Costs and expenses include stock-based compensation expense as follows (in thousands):

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

Cost of revenue

$

2,818

 

$

2,466

 

$

8,373

 

$

7,205

Research and development

 

4,471

 

 

3,080

 

 

14,602

 

 

8,874

Sales and marketing

 

6,487

 

 

4,060

 

 

19,881

 

 

12,752

General and administrative

 

5,592

 

 

2,165

 

 

11,470

 

 

6,742

Restructuring

 

—

 

 

—

 

 

—

 

 

3,646

Total stock-based compensation expense

$

19,368

 

$

11,771

 

$

54,326

 

$

39,219

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

$

75,196

 

 

$

47,956

 

 

$

160,727

 

 

$

106,964

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

2,655

 

 

 

2,509

 

 

 

7,830

 

 

 

7,717

 

Deferred income taxes

 

1,992

 

 

 

—

 

 

 

2,196

 

 

 

—

 

Stock-based compensation, net of amounts capitalized

 

19,368

 

 

 

11,771

 

 

 

54,326

 

 

 

39,219

 

Non-cash lease expense

 

441

 

 

 

522

 

 

 

1,392

 

 

 

1,599

 

Accretion of discount on marketable securities, net

 

(3,368

)

 

 

(1,683

)

 

 

(8,736

)

 

 

(3,477

)

Amortization of deferred contract costs

 

1,785

 

 

 

1,548

 

 

 

6,544

 

 

 

6,278

 

Impairment of long-lived assets

 

—

 

 

 

—

 

 

 

2,304

 

 

 

—

 

Other

 

411

 

 

 

1,500

 

 

 

289

 

 

 

1,627

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

(12,986

)

 

 

(1,135

)

 

 

(36,464

)

 

 

8,509

 

Prepaid expenses and other assets

 

1,303

 

 

 

6,523

 

 

 

21,251

 

 

 

(3,981

)

Deferred contract costs

 

(5,853

)

 

 

(4,477

)

 

 

(9,069

)

 

 

(6,925

)

Accounts payable, accrued expenses and other liabilities

 

9,418

 

 

 

10,429

 

 

 

3,872

 

 

 

2,366

 

Deferred revenue

 

(24,628

)

 

 

(24,823

)

 

 

(30,085

)

 

 

(38,576

)

Operating lease liabilities

 

(545

)

 

 

(586

)

 

 

(1,599

)

 

 

(1,168

)

Net cash provided by operating activities

 

65,189

 

 

 

50,054

 

 

 

174,778

 

 

 

120,152

 

Cash flows from investing activities

 

 

 

 

 

 

 

Purchases of property and equipment

 

—

 

 

 

(36

)

 

 

—

 

 

 

(147

)

Internal-use software development costs

 

(1,771

)

 

 

(1,288

)

 

 

(5,018

)

 

 

(4,020

)

Purchases of marketable securities

 

(164,025

)

 

 

(101,112

)

 

 

(531,833

)

 

 

(281,338

)

Maturities of marketable securities

 

99,308

 

 

 

105,418

 

 

 

517,221

 

 

 

318,186

 

Sales of marketable securities

 

7,564

 

 

 

37,150

 

 

 

14,805

 

 

 

74,675

 

Net cash provided by (used in) investing activities

 

(58,924

)

 

 

40,132

 

 

 

(4,825

)

 

 

107,356

 

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from issuance of common stock upon exercise of stock options and common stock warrants

 

3,662

 

 

 

2,540

 

 

 

13,905

 

 

 

9,758

 

Proceeds from issuance of common stock in connection with the employee stock purchase plan

 

—

 

 

 

—

 

 

 

1,422

 

 

 

1,494

 

Taxes paid related to net share settlement of equity awards

 

(8,107

)

 

 

(1,248

)

 

 

(16,329

)

 

 

(5,332

)

Repurchase of common stock

 

(19,307

)

 

 

(76,792

)

 

 

(93,505

)

 

 

(262,976

)

Payment of contingent consideration related to a business combination

 

—

 

 

 

—

 

 

 

(5,470

)

 

 

(5,390

)

Payment of excise taxes on share repurchases

 

(1,491

)

 

 

—

 

 

 

(1,491

)

 

 

—

 

Net cash used in financing activities

 

(25,243

)

 

 

(75,500

)

 

 

(101,468

)

 

 

(262,446

)

Net increase (decrease) in cash and cash equivalents

 

(18,978

)

 

 

14,686

 

 

 

68,485

 

 

 

(34,938

)

Cash and cash equivalents, beginning of period

 

184,248

 

 

 

108,403

 

 

 

96,785

 

 

 

158,027

 

Cash and cash equivalents, end of period

$

165,270

 

 

$

123,089

 

 

$

165,270

 

 

$

123,089

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

Cash paid for taxes, net of refunds

$

13,829

 

 

$

8,925

 

 

$

35,814

 

 

$

38,363

 

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

• Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, change in fair value of contingent earn-out consideration liability, and restructuring and impairment charges from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.

• Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for stock-based compensation expense, change in fair value of contingent earn-out consideration liability, restructuring and impairment charges, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.

• Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

• Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.

• Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments. 

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(unaudited)

 

(in thousands, except percentages)

Net income

$

75,196

 

 

$

47,956

 

 

$

160,727

 

 

$

106,964

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

19,368

 

 

 

11,771

 

 

 

54,326

 

 

 

35,573

 

Depreciation and amortization

 

2,655

 

 

 

2,509

 

 

 

7,830

 

 

 

7,717

 

Provision for income taxes

 

14,644

 

 

 

15,076

 

 

 

44,453

 

 

 

30,285

 

Restructuring and impairment charges

 

—

 

 

 

—

 

 

 

2,304

 

 

 

7,936

 

Change in fair value of contingent earn-out consideration liability

 

90

 

 

 

452

 

 

 

513

 

 

 

768

 

Other income, net

 

(9,915

)

 

 

(4,481

)

 

 

(26,060

)

 

 

(15,223

)

Adjusted EBITDA

$

102,038

 

 

$

73,283

 

 

$

244,093

 

 

$

174,020

 

 

 

 

 

 

 

 

 

Revenue

$

168,603

 

 

$

135,284

 

 

$

432,111

 

 

$

357,365

 

Net income margin

 

44.6

%

 

 

35.4

%

 

 

37.2

%

 

 

29.9

%

Adjusted EBITDA margin

 

60.5

%

 

 

54.2

%

 

 

56.5

%

 

 

48.7

%

 

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(unaudited)

 

(in thousands)

Net cash provided by operating activities

$

65,189

 

 

$

50,054

 

 

$

174,778

 

 

$

120,152

 

Purchases of property and equipment

 

—

 

 

 

(36

)

 

 

—

 

 

 

(147

)

Internal-use software development costs

 

(1,771

)

 

 

(1,288

)

 

 

(5,018

)

 

 

(4,020

)

Free cash flow

$

63,418

 

 

$

48,730

 

 

$

169,760

 

 

$

115,985

 

Other cash flow components:

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

$

(58,924

)

 

$

40,132

 

 

$

(4,825

)

 

$

107,356

 

Net cash used in financing activities

$

(25,243

)

 

$

(75,500

)

 

$

(101,468

)

 

$

(262,446

)

Three Months Ended December 31,

 

Nine Months Ended December 31,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(unaudited)

 

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

14,181

 

 

$

12,190

 

 

$

41,407

 

 

$

38,102

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(2,818

)

 

 

(2,466

)

 

 

(8,373

)

 

 

(7,205

)

Amortization of acquired intangibles

 

—

 

 

 

—

 

 

 

—

 

 

 

(274

)

Non-GAAP cost of revenue

$

11,363

 

 

$

9,724

 

 

$

33,034

 

 

$

30,623

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

154,422

 

 

$

123,094

 

 

$

390,704

 

 

$

319,263

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

2,818

 

 

 

2,466

 

 

 

8,373

 

 

 

7,205

 

Amortization of acquired intangibles

 

—

 

 

 

—

 

 

 

—

 

 

 

274

 

Non-GAAP gross profit

$

157,240

 

 

$

125,560

 

 

$

399,077

 

 

$

326,742

 

 

 

 

 

 

 

 

 

GAAP gross margin

 

91.6

%

 

 

91.0

%

 

 

90.4

%

 

 

89.3

%

Non-GAAP gross margin

 

93.3

%

 

 

92.8

%

 

 

92.4

%

 

 

91.4

%

 

 

 

 

 

 

 

 

GAAP research and development expense

$

22,421

 

 

$

19,946

 

 

$

68,235

 

 

$

61,835

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(4,471

)

 

 

(3,080

)

 

 

(14,602

)

 

 

(8,874

)

Non-GAAP research and development expense

$

17,950

 

 

$

16,866

 

 

$

53,633

 

 

$

52,961

 

 

 

 

 

 

 

 

 

GAAP sales and marketing expense

$

38,491

 

 

$

34,956

 

 

$

108,102

 

 

$

99,612

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(6,487

)

 

 

(4,060

)

 

 

(19,881

)

 

 

(12,752

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(1,061

)

 

 

(3,183

)

 

 

(3,183

)

Change in fair value of contingent earn-out consideration liability

 

(90

)

 

 

(452

)

 

 

(513

)

 

 

(768

)

Non-GAAP sales and marketing expense

$

30,853

 

 

$

29,383

 

 

$

84,525

 

 

$

82,909

 

 

 

 

 

 

 

 

 

GAAP general and administrative expense

$

13,585

 

 

$

9,641

 

 

$

32,943

 

 

$

27,854

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(5,592

)

 

 

(2,165

)

 

 

(11,470

)

 

 

(6,742

)

Non-GAAP general and administrative expense

$

7,993

 

 

$

7,476

 

 

$

21,473

 

 

$

21,112

 

 

 

 

 

 

 

 

 

GAAP operating expense

$

74,497

 

 

$

64,543

 

 

$

211,584

 

 

$

197,237

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(16,550

)

 

 

(9,305

)

 

 

(45,953

)

 

 

(28,368

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(1,061

)

 

 

(3,183

)

 

 

(3,183

)

Change in fair value of contingent earn-out consideration liability

 

(90

)

 

 

(452

)

 

 

(513

)

 

 

(768

)

Restructuring and impairment charges

 

—

 

 

 

—

 

 

 

(2,304

)

 

 

(7,936

)

Non-GAAP operating expense

$

56,796

 

 

$

53,725

 

 

$

159,631

 

 

$

156,982

 

 

 

 

 

 

 

 

 

GAAP operating income

$

79,925

 

 

$

58,551

 

 

$

179,120

 

 

$

122,026

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

19,368

 

 

 

11,771

 

 

 

54,326

 

 

 

35,573

 

Amortization of acquired intangibles

 

1,061

 

 

 

1,061

 

 

 

3,183

 

 

 

3,457

 

Change in fair value of contingent earn-out consideration liability

 

90

 

 

 

452

 

 

 

513

 

 

 

768

 

Restructuring and impairment charges

 

—

 

 

 

—

 

 

 

2,304

 

 

 

7,936

 

Non-GAAP operating income

$

100,444

 

 

$

71,835

 

 

$

239,446

 

 

$

169,760

 

 

 

 

 

 

 

 

 

GAAP net income

$

75,196

 

 

$

47,956

 

 

$

160,727

 

 

$

106,964

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

19,368

 

 

 

11,771

 

 

 

54,326

 

 

 

35,573

 

Amortization of acquired intangibles

 

1,061

 

 

 

1,061

 

 

 

3,183

 

 

 

3,457

 

Change in fair value of contingent earn-out consideration liability

 

90

 

 

 

452

 

 

 

513

 

 

 

768

 

Restructuring and impairment charges

 

—

 

 

 

—

 

 

 

2,304

 

 

 

7,936

 

Income tax effect of non-GAAP adjustments (1)

 

(4,309

)

 

 

(2,790

)

 

 

(12,668

)

 

 

(10,024

)

Non-GAAP net income

$

91,406

 

 

$

58,450

 

 

$

208,385

 

 

$

144,674

 

Non-GAAP net income margin

 

54.2

%

 

 

43.2

%

 

 

48.2

%

 

 

40.5

%

 

 

 

 

 

 

 

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

187,161

 

 

 

186,309

 

 

 

186,344

 

 

 

191,302

 

Diluted

 

202,233

 

 

 

200,463

 

 

 

200,625

 

 

 

207,265

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share attributable to Class A and Class B stockholders:

 

 

 

 

 

 

 

Basic

$

0.49

 

 

$

0.31

 

 

$

1.12

 

 

$

0.76

 

Diluted

$

0.45

 

 

$

0.29

 

 

$

1.04

 

 

$

0.70

 

(1) For the three and nine months ended December 31, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250206576423/en/

Investor Relations Contact: Perry Gold [e-mail]

Media Contact: Amanda Cox [e-mail]